Foundry Operating Profitability Industry-Neutral Factor ETF
ETF Foundry Research (hypothetical) · rebalanced monthly
Every other metric on this page is the long-shortstrategy, which needs a short book. This fund is the long leg alone, so these are the figures for what it actually holds. The bottom-bucket number is that basket’s own return — not short P&L.
Hypothetical growth of $1 — long-short backtest
Gross of the placeholder expense ratio and trading costs · not investor results
Holdings
Every constituent of the long leg — sort, search or filter by sector
| Ticker | Company | Sector | Market cap | Weight |
|---|---|---|---|---|
1AAPL | APPLE INC | Technology | $4.90T | 33.83% |
2LLY | ELI LILLY & CO | Healthcare | $1.11T | 7.66% |
3JNJ | JOHNSON & JOHNSON | Healthcare | $609.12B | 4.20% |
4MA | MASTERCARD INC | Financial Services | $480.32B | 3.31% |
5CAT | CATERPILLAR INC | Industrials | $405.49B | 2.80% |
6LRCX | LAM RESEARCH CORP | Technology | $391.80B | 2.70% |
7GE | GE AEROSPACE | Industrials | $361.93B | 2.50% |
8HD | HOME DEPOT INC | Consumer Cyclical | $337.89B | 2.33% |
9MRK | MERCK & CO INC | Healthcare | $314.90B | 2.17% |
10GEV | GE VERNOVA INC | Utilities | $284.26B | 1.96% |
11KLAC | KLA CORP | Technology | $277.91B | 1.92% |
12LIN | LINDE PLC | Basic Materials | $237.42B | 1.64% |
13AMGN | AMGEN INC | Healthcare | $197.69B | 1.36% |
14STX | SEAGATE TECHNOLOGY HOLDINGS PLC | Technology | $176.62B | 1.22% |
15ABT | ABBOTT LABORATORIES | Healthcare | $175.37B | 1.21% |
16GILD | GILEAD SCIENCES INC | Healthcare | $166.72B | 1.15% |
17PFE | PFIZER INC | Healthcare | $142.77B | 0.99% |
18APP | APPLOVIN CORP | Technology | $142.62B | 0.98% |
19BMY | BRISTOL MYERS SQUIBB CO | Healthcare | $124.04B | 0.86% |
20VRTX | VERTEX PHARMACEUTICALS INC | Healthcare | $123.26B | 0.85% |
21SYK | STRYKER CORP | Healthcare | $122.63B | 0.85% |
22ISRG | INTUITIVE SURGICAL INC | Healthcare | $122.33B | 0.84% |
23FTNT | FORTINET INC | Technology | $118.40B | 0.82% |
24LMT | LOCKHEED MARTIN CORP | Industrials | $117.30B | 0.81% |
25TT | TRANE TECHNOLOGIES PLC | Basic Materials | $103.89B | 0.72% |
26WM | WASTE MANAGEMENT INC | Industrials | $96.10B | 0.66% |
27MNST | MONSTER BEVERAGE CORP | Consumer Defensive | $95.36B | 0.66% |
28MCO | MOODYS CORP | Financial Services | $89.25B | 0.62% |
29MMM | 3M CO | Industrials | $83.37B | 0.58% |
30ITW | ILLINOIS TOOL WORKS INC | Industrials | $79.42B | 0.55% |
31AMT | AMERICAN TOWER CORP | Real Estate | $79.23B | 0.55% |
32EMR | EMERSON ELECTRIC CO | Industrials | $78.14B | 0.54% |
33CL | COLGATE PALMOLIVE CO | Consumer Defensive | $74.40B | 0.51% |
34REGN | REGENERON PHARMACEUTICALS INC | Healthcare | $70.94B | 0.49% |
35MSI | MOTOROLA SOLUTIONS INC | Technology | $68.61B | 0.47% |
36APD | AIR PRODUCTS & CHEMICALS INC | Basic Materials | $65.83B | 0.45% |
37BSX | BOSTON SCIENTIFIC CORP | Healthcare | $65.44B | 0.45% |
38BE | BLOOM ENERGY CORP | Industrials | $61.14B | 0.42% |
39COR | CENCORA INC | Healthcare | $59.91B | 0.41% |
40AME | AMETEK INC | Industrials | $54.32B | 0.37% |
41ROK | ROCKWELL AUTOMATION INC | Industrials | $51.39B | 0.35% |
42TER | TERADYNE INC | Technology | $50.46B | 0.35% |
43EW | EDWARDS LIFESCIENCES CORP | Healthcare | $49.36B | 0.34% |
44IDXX | IDEXX LABORATORIES INC | Healthcare | $44.76B | 0.31% |
45SYY | SYSCO CORP | Consumer Defensive | $39.06B | 0.27% |
46TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Healthcare | $37.30B | 0.26% |
47RBLX | ROBLOX CORP | Communication Services | $37.02B | 0.26% |
48KMB | KIMBERLY CLARK CORP | Consumer Defensive | $35.97B | 0.25% |
49ALNY | ALNYLAM PHARMACEUTICALS INC | Healthcare | $35.71B | 0.25% |
50ONC | BEONE MEDICINES LTD | Healthcare | $34.68B | 0.24% |
51UI | UBIQUITI INC | Technology | $33.04B | 0.23% |
52EXPE | EXPEDIA GROUP INC | Industrials | $32.26B | 0.22% |
53NTAP | NETAPP INC | Technology | $32.11B | 0.22% |
54ZTS | ZOETIS INC | Healthcare | $32.10B | 0.22% |
55JBL | JABIL INC | Technology | $31.54B | 0.22% |
56BIIB | BIOGEN INC | Healthcare | $30.41B | 0.21% |
57CQP | CHENIERE ENERGY PARTNERS LP | Energy | $30.20B | 0.21% |
58LVS | LAS VEGAS SANDS CORP | Consumer Cyclical | $30.06B | 0.21% |
59DXCM | DEXCOM INC | Healthcare | $29.58B | 0.20% |
60RMD | RESMED INC | Healthcare | $28.86B | 0.20% |
61GEHC | GE HEALTHCARE TECHNOLOGIES INC | Healthcare | $28.69B | 0.20% |
62TPR | TAPESTRY INC | Consumer Cyclical | $28.58B | 0.20% |
63ILMN | ILLUMINA INC | Healthcare | $28.24B | 0.19% |
64PPG | PPG INDUSTRIES INC | Basic Materials | $26.16B | 0.18% |
65TEAM | ATLASSIAN CORP | Technology | $23.67B | 0.16% |
66WWD | WOODWARD INC | Industrials | $23.41B | 0.16% |
67VLTO | VERALTO CORP | Industrials | $23.04B | 0.16% |
68UTHR | UNITED THERAPEUTICS CORP | Healthcare | $22.74B | 0.16% |
69DOW | DOW INC | Basic Materials | $21.56B | 0.15% |
70FTAI | FTAI AVIATION LTD | Industrials | $21.28B | 0.15% |
71IFF | INTERNATIONAL FLAVORS & FRAGRANCES INC | Basic Materials | $19.96B | 0.14% |
72LYB | LYONDELLBASELL INDUSTRIES NV | Basic Materials | $19.10B | 0.13% |
73LII | LENNOX INTERNATIONAL INC | Basic Materials | $18.93B | 0.13% |
74CF | CF INDUSTRIES HOLDINGS INC | Basic Materials | $18.65B | 0.13% |
75DD | DUPONT DE NEMOURS INC | Basic Materials | $18.49B | 0.13% |
76NBIX | NEUROCRINE BIOSCIENCES INC | Healthcare | $17.18B | 0.12% |
77THC | TENET HEALTHCARE CORP | Healthcare | $16.79B | 0.12% |
78CHTR | CHARTER COMMUNICATIONS INC | Communication Services | $16.16B | 0.11% |
79JAZZ | JAZZ PHARMACEUTICALS PLC | Healthcare | $15.53B | 0.11% |
80ALB | ALBEMARLE CORP | Basic Materials | $14.24B | 0.10% |
81EQH | EQUITABLE HOLDINGS INC | Financial Services | $13.79B | 0.10% |
82RPM | RPM INTERNATIONAL INC | Basic Materials | $13.41B | 0.09% |
83MDGL | MADRIGAL PHARMACEUTICALS INC | Healthcare | $12.76B | 0.09% |
84GNRC | GENERAC HOLDINGS INC | Industrials | $12.65B | 0.09% |
85GDDY | GODADDY INC | Technology | $12.49B | 0.09% |
86AXSM | AXSOME THERAPEUTICS INC | Healthcare | $11.84B | 0.08% |
87HAS | HASBRO INC | Consumer Cyclical | $11.54B | 0.08% |
88BMRN | BIOMARIN PHARMACEUTICAL INC | Healthcare | $11.52B | 0.08% |
89MUSA | MURPHY USA INC | Consumer Cyclical | $11.43B | 0.08% |
90PODD | INSULET CORP | Healthcare | $11.36B | 0.08% |
91SCI | SERVICE CORP INTERNATIONAL | Consumer Cyclical | $10.86B | 0.07% |
92ARWR | ARROWHEAD PHARMACEUTICALS INC | Healthcare | $10.47B | 0.07% |
93LFUS | LITTELFUSE INC | Technology | $10.06B | 0.07% |
94AYI | ACUITY INC (DE) | Industrials | $9.99B | 0.07% |
95WLK | WESTLAKE CORP | Basic Materials | $9.95B | 0.07% |
96CORT | CORCEPT THERAPEUTICS INC | Healthcare | $9.72B | 0.07% |
97MANH | MANHATTAN ASSOCIATES INC | Technology | $9.66B | 0.07% |
98IT | GARTNER INC | Technology | $9.39B | 0.06% |
99HALO | HALOZYME THERAPEUTICS INC | Healthcare | $9.23B | 0.06% |
100ESI | ELEMENT SOLUTIONS INC | Basic Materials | $9.11B | 0.06% |
101IONS | IONIS PHARMACEUTICALS INC | Healthcare | $8.99B | 0.06% |
102ALKS | ALKERMES PLC | Healthcare | $8.79B | 0.06% |
103POWL | POWELL INDUSTRIES INC | Industrials | $8.48B | 0.06% |
104GLXY | GALAXY DIGITAL INC | Financial Services | $8.43B | 0.06% |
105TGTX | TG THERAPEUTICS INC | Healthcare | $8.40B | 0.06% |
106HESM | HESS MIDSTREAM LP | Energy | $8.32B | 0.06% |
107EAT | BRINKER INTERNATIONAL INC | Consumer Cyclical | $8.12B | 0.06% |
108EMN | EASTMAN CHEMICAL CO | Basic Materials | $7.84B | 0.05% |
109HXL | HEXCEL CORP | Industrials | $7.83B | 0.05% |
110HIMS | HIMS & HERS HEALTH INC | Consumer Defensive | $7.60B | 0.05% |
111YOU | CLEAR SECURE INC | Technology | $7.49B | 0.05% |
112CELH | CELSIUS HOLDINGS INC | Consumer Defensive | $7.41B | 0.05% |
113MIRM | MIRUM PHARMACEUTICALS INC | Healthcare | $7.25B | 0.05% |
114LQDA | LIQUIDIA CORP | Healthcare | $7.11B | 0.05% |
115NEU | NEWMARKET CORP | Basic Materials | $7.08B | 0.05% |
116MOS | MOSAIC CO | Basic Materials | $7.03B | 0.05% |
117LNTH | LANTHEUS HOLDINGS INC | Healthcare | $7.00B | 0.05% |
118AXTA | AXALTA COATING SYSTEMS LTD | Basic Materials | $6.92B | 0.05% |
119RRR | RED ROCK RESORTS INC | Consumer Cyclical | $6.76B | 0.05% |
120MSA | MSA SAFETY INC | Industrials | $6.60B | 0.05% |
121CVLT | COMMVAULT SYSTEMS INC | Technology | $6.10B | 0.04% |
122SEZL | SEZZLE INC | Financial Services | $5.87B | 0.04% |
123PRM | PERIMETER SOLUTIONS INC | Basic Materials | $5.61B | 0.04% |
124DAVE | DAVE INC | Technology | $5.60B | 0.04% |
125FTDR | FRONTDOOR INC | Consumer Cyclical | $5.32B | 0.04% |
126NOVT | NOVANTA INC | Technology | $5.30B | 0.04% |
127TVTX | TRAVERE THERAPEUTICS INC | Healthcare | $5.27B | 0.04% |
128BCPC | BALCHEM CORP | Basic Materials | $5.25B | 0.04% |
129LAUR | LAUREATE EDUCATION INC | Consumer Defensive | $5.10B | 0.04% |
130CHH | CHOICE HOTELS INTERNATIONAL INC | Consumer Cyclical | $5.09B | 0.04% |
131PAGP | PLAINS GP HOLDINGS LP | Energy | $5.07B | 0.03% |
132CE | CELANESE CORP | Basic Materials | $5.01B | 0.03% |
133KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | Healthcare | $4.92B | 0.03% |
134FELE | FRANKLIN ELECTRIC CO INC | Industrials | $4.67B | 0.03% |
135CBT | CABOT CORP | Basic Materials | $4.67B | 0.03% |
136SXT | SENSIENT TECHNOLOGIES CORP | Basic Materials | $4.64B | 0.03% |
137CSW | CSW INDUSTRIALS INC | Industrials | $4.56B | 0.03% |
138LIVN | LIVANOVA PLC | Healthcare | $4.43B | 0.03% |
139AZZ | AZZ INC | Industrials | $4.42B | 0.03% |
140ACAD | ACADIA PHARMACEUTICALS INC | Healthcare | $4.38B | 0.03% |
141PJT | PJT PARTNERS INC | Financial Services | $4.30B | 0.03% |
142CAKE | CHEESECAKE FACTORY INC | Consumer Cyclical | $4.26B | 0.03% |
143VNT | VONTIER CORP | Technology | $4.25B | 0.03% |
144GFF | GRIFFON CORP | Industrials | $4.20B | 0.03% |
145EXTR | EXTREME NETWORKS INC | Technology | $3.97B | 0.03% |
146CPRX | CATALYST PHARMACEUTICALS INC | Healthcare | $3.85B | 0.03% |
147LOPE | GRAND CANYON EDUCATION INC | Consumer Defensive | $3.72B | 0.03% |
148LRN | STRIDE INC | Consumer Defensive | $3.71B | 0.03% |
149ARQT | ARCUTIS BIOTHERAPEUTICS INC | Healthcare | $3.56B | 0.02% |
150RH | RH | Consumer Cyclical | $3.55B | 0.02% |
151OGN | ORGANON & CO | Healthcare | $3.55B | 0.02% |
152HAE | HAEMONETICS CORP | Healthcare | $3.54B | 0.02% |
153RCUS | ARCUS BIOSCIENCES INC | Healthcare | $3.44B | 0.02% |
154AVNT | AVIENT CORP | Basic Materials | $3.39B | 0.02% |
155WDFC | WD 40 CO | Basic Materials | $3.31B | 0.02% |
156ITGR | INTEGER HOLDINGS CORP | Healthcare | $3.24B | 0.02% |
157CARG | CARGURUS INC | Consumer Cyclical | $3.16B | 0.02% |
158FUL | FULLER H B CO | Basic Materials | $3.06B | 0.02% |
159AAMI | ACADIAN ASSET MANAGEMENT INC | Financial Services | $2.95B | 0.02% |
160FIZZ | NATIONAL BEVERAGE CORP | Consumer Defensive | $2.91B | 0.02% |
161TNET | TRINET GROUP INC | Industrials | $2.74B | 0.02% |
162APAM | ARTISAN PARTNERS ASSET MANAGEMENT INC | Financial Services | $2.73B | 0.02% |
163GRND | GRINDR INC | Technology | $2.71B | 0.02% |
164UNIT | UNITI GROUP INC | Real Estate | $2.68B | 0.02% |
165NGVT | INGEVITY CORP | Basic Materials | $2.66B | 0.02% |
166CC | CHEMOURS CO | Basic Materials | $2.63B | 0.02% |
167GCMG | GCM GROSVENOR INC | Financial Services | $2.61B | 0.02% |
168FLNC | FLUENCE ENERGY INC | Utilities | $2.59B | 0.02% |
169TMDX | TRANSMEDICS GROUP INC | Healthcare | $2.56B | 0.02% |
170DRVN | DRIVEN BRANDS HOLDINGS INC | Consumer Cyclical | $2.51B | 0.02% |
171OLN | OLIN CORP | Basic Materials | $2.50B | 0.02% |
172ATKR | ATKORE INC | Industrials | $2.48B | 0.02% |
173ROG | ROGERS CORP | Technology | $2.36B | 0.02% |
174MTX | MINERALS TECHNOLOGIES INC | Basic Materials | $2.32B | 0.02% |
175IOSP | INNOSPEC INC | Basic Materials | $2.08B | 0.01% |
176HUN | HUNTSMAN CORP | Basic Materials | $2.07B | 0.01% |
177AUPH | AURINIA PHARMACEUTICALS INC | Healthcare | $2.05B | 0.01% |
178ADMA | ADMA BIOLOGICS INC | Healthcare | $2.02B | 0.01% |
179HRMY | HARMONY BIOSCIENCES HOLDINGS INC | Healthcare | $1.96B | 0.01% |
180NSP | INSPERITY INC | Industrials | $1.89B | 0.01% |
181CPRI | CAPRI HOLDINGS LTD | Consumer Cyclical | $1.89B | 0.01% |
182FLOC | FLOWCO HOLDINGS INC | Energy | $1.83B | 0.01% |
183SRPT | SAREPTA THERAPEUTICS INC | Healthcare | $1.82B | 0.01% |
184ANIP | ANI PHARMACEUTICALS INC | Healthcare | $1.80B | 0.01% |
185IMCR | IMMUNOCORE HOLDINGS PLC | Healthcare | $1.78B | 0.01% |
186HROW | HARROW INC | Healthcare | $1.74B | 0.01% |
187ANAB | ANAPTYSBIO INC | Healthcare | $1.69B | 0.01% |
188GLP | GLOBAL PARTNERS LP | Energy | $1.63B | 0.01% |
189AMSC | AMERICAN SUPERCONDUCTOR CORP | Industrials | $1.58B | 0.01% |
190REX | REX AMERICAN RESOURCES CORP | Basic Materials | $1.56B | 0.01% |
191XERS | XERIS BIOPHARMA HOLDINGS INC | Healthcare | $1.52B | 0.01% |
192BRUN | BOOST RUN INC | Technology | $1.50B | 0.01% |
193BLKB | BLACKBAUD INC | Technology | $1.49B | 0.01% |
194LILA | LIBERTY LATIN AMERICA LTD | Communication Services | $1.48B | 0.01% |
195WEN | WENDY'S CO | Consumer Cyclical | $1.48B | 0.01% |
196YELP | YELP INC | Communication Services | $1.44B | 0.01% |
197AIP | ARTERIS INC | Technology | $1.43B | 0.01% |
198ECVT | ECOVYST INC | Basic Materials | $1.41B | 0.01% |
199FMC | FMC CORP | Basic Materials | $1.40B | 0.01% |
200ENR | ENERGIZER HOLDINGS INC | Industrials | $1.39B | 0.01% |
201PAHC | PHIBRO ANIMAL HEALTH CORP | Healthcare | $1.35B | 0.01% |
202GPRE | GREEN PLAINS INC | Basic Materials | $1.35B | 0.01% |
203PBT | PERMIAN BASIN ROYALTY TRUST | Energy | $1.32B | 0.01% |
204UAN | CVR PARTNERS LP | Basic Materials | $1.26B | 0.01% |
205TDAY | USA TODAY CO INC | Consumer Cyclical | $1.25B | 0.01% |
206NBR | NABORS INDUSTRIES LTD | Energy | $1.24B | 0.01% |
207IRMD | IRADIMED CORP | Healthcare | $1.24B | 0.01% |
208CBRL | CRACKER BARREL OLD COUNTRY STORE INC | Consumer Cyclical | $1.20B | 0.01% |
209TNDM | TANDEM DIABETES CARE INC | Healthcare | $1.17B | 0.01% |
210COLL | COLLEGIUM PHARMACEUTICAL INC | Healthcare | $1.17B | 0.01% |
211ETON | ETON PHARMACEUTICALS INC | Healthcare | $1.16B | 0.01% |
212CRAI | CRA INTERNATIONAL INC | Industrials | $1.11B | 0.01% |
213RHLD | RESOLUTE HOLDINGS MANAGEMENT INC | Industrials | $1.10B | 0.01% |
214PCT | PURECYCLE TECHNOLOGIES INC | Industrials | $1.09B | 0.01% |
215PXED | PHOENIX EDUCATION PARTNERS INC | Consumer Defensive | $1.09B | 0.01% |
216PCRX | PACIRA BIOSCIENCES INC | Healthcare | $1.01B | 0.01% |
217BVS | BIOVENTUS INC | Healthcare | $1.01B | 0.01% |
218FTK | FLOTEK INDUSTRIES INC | Energy | $947M | 0.01% |
219ADTN | ADTRAN HOLDINGS INC | Technology | $944M | 0.01% |
220TROX | TRONOX HOLDINGS PLC | Basic Materials | $932M | 0.01% |
221ARKO | ARKO CORP | Consumer Cyclical | $893M | 0.01% |
222MAX | MEDIAALPHA INC | Communication Services | $880M | 0.01% |
223LYTS | LSI INDUSTRIES INC | Technology | $879M | 0.01% |
224AMPH | AMPHASTAR PHARMACEUTICALS INC | Healthcare | $871M | 0.01% |
225TDUP | THREDUP INC | Consumer Cyclical | $852M | 0.01% |
226INR | INFINITY NATURAL RESOURCES INC | Energy | $826M | 0.01% |
227LXU | LSB INDUSTRIES INC | Basic Materials | $819M | 0.01% |
228OPFI | OPPFI INC | Financial Services | $801M | 0.01% |
229WLKP | WESTLAKE CHEMICAL PARTNERS LP | Basic Materials | $776M | 0.01% |
230KRO | KRONOS WORLDWIDE INC | Basic Materials | $757M | 0.01% |
231DSP | VIANT TECHNOLOGY INC | Technology | $754M | 0.01% |
232RIGL | RIGEL PHARMACEUTICALS INC | Healthcare | $750M | 0.01% |
233CCSI | CONSENSUS CLOUD SOLUTIONS INC | Technology | $689M | 0.00% |
234CRMD | CORMEDIX INC | Healthcare | $661M | 0.00% |
235KLC | KINDERCARE LEARNING COMPANIES INC | Consumer Defensive | $618M | 0.00% |
236ASIX | ADVANSIX INC | Basic Materials | $561M | 0.00% |
237RYAM | RAYONIER ADVANCED MATERIALS INC | Basic Materials | $555M | 0.00% |
238NPCE | NEUROPACE INC | Healthcare | $548M | 0.00% |
239YEXT | YEXT INC | Technology | $535M | 0.00% |
240NRC | NRC HEALTH | Healthcare | $491M | 0.00% |
241ALTO | ALTO INGREDIENTS INC | Basic Materials | $453M | 0.00% |
242DCTH | DELCATH SYSTEMS INC | Healthcare | $442M | 0.00% |
243LXFR | LUXFER HOLDINGS PLC | Industrials | $442M | 0.00% |
244FWRD | FORWARD AIR CORP | Industrials | $435M | 0.00% |
245PBYI | PUMA BIOTECHNOLOGY INC | Healthcare | $434M | 0.00% |
246SGU | STAR GROUP LP | Energy | $430M | 0.00% |
247EBS | EMERGENT BIOSOLUTIONS INC | Healthcare | $394M | 0.00% |
248VHI | VALHI INC | Basic Materials | $393M | 0.00% |
249OEC | ORION SA | Basic Materials | $386M | 0.00% |
250NATR | NATURES SUNSHINE PRODUCTS INC | Consumer Defensive | $359M | 0.00% |
251PLAY | DAVE & BUSTER'S ENTERTAINMENT INC | Communication Services | $355M | 0.00% |
252ELMD | ELECTROMED INC | Healthcare | $349M | 0.00% |
253BKKT | BAKKT INC | Technology | $323M | 0.00% |
254ALDF | ALDEL FINANCIAL II INC | Industrials | $320M | 0.00% |
255NL | NL INDUSTRIES INC | Industrials | $288M | 0.00% |
256QTTB | Q32 BIO INC | Healthcare | $255M | 0.00% |
257RILY | BRC GROUP HOLDINGS INC | Financial Services | $254M | 0.00% |
258GTE | GRAN TIERRA ENERGY INC | Energy | $233M | 0.00% |
259SMTI | SANARA MEDTECH INC | Healthcare | $229M | 0.00% |
260STRW | STRAWBERRY FIELDS REIT INC | Real Estate | $190M | 0.00% |
261PDEX | PRO DEX INC | Healthcare | $183M | 0.00% |
262VTVT | VTV THERAPEUTICS INC | Healthcare | $130M | 0.00% |
263CUE | CUE BIOPHARMA INC | Healthcare | $126M | 0.00% |
264FTLF | FITLIFE BRANDS INC | Consumer Defensive | $104M | 0.00% |
265ULBI | ULTRALIFE CORP | Industrials | $92M | 0.00% |
266SOTK | SONO TEK CORP | Technology | $86M | 0.00% |
267CSBR | CHAMPIONS ONCOLOGY INC | Healthcare | $85M | 0.00% |
268FSI | FLEXIBLE SOLUTIONS INTERNATIONAL INC | Basic Materials | $76M | 0.00% |
269BODI | BEACHBODY COMPANY INC | Communication Services | $75M | 0.00% |
270LNZA | LANZATECH GLOBAL INC | Industrials | $56M | 0.00% |
271SNWV | SANUWAVE HEALTH INC | Healthcare | $55M | 0.00% |
272XLO | XILIO THERAPEUTICS INC | Healthcare | $53M | 0.00% |
Full long-leg book as of July 2026 · cap-weighted · total market cap $14.49T. Hypothetical model holdings — not a registered fund’s portfolio.
Sector Breakdown
Portfolio Style
Size × value map of the long-leg book
Share of long-leg capital by market cap × book-to-market, using terciles of the 3,283-name universe at July 2026. Rows: Large ≥ $5.2B, Small < $819M. Columns: Value ≥ 0.62, Growth < 0.34 B/M. The dot marks the capital-weighted centroid of the book — 99% toward Large, 85% toward Growth. +1% unclassified (19 missing size/value). Hypothetical holdings — descriptive, not realized P&L.
Capital-weighted centroid of the long leg, December 1998 → July 2026; the right-hand end is the same value as the box’s dot. 272 names now. Hypothetical holdings — descriptive, not P&L.
Constraint checks
How this book measures against the concentration and liquidity rules — as implemented here
These are UNCONSTRAINED factor sleeves: the construction pipeline sorts on a signal and cap-weights the top bucket, applying no issuer cap, no industry cap and no liquidity screen beyond the universe filter. A failing test therefore reports a constraint that was never applied during construction — it is not a defect in the strategy and not an error in the data. The same signal can be solved subject to these constraints.
7 independent checks plus 1 arithmetically implied by another check (RIC / IRC 851(b)(3)(A) 50% bucket), which is reported separately so the tally cannot overstate scrutiny.
2 of 7 checks could not be tested. Those are neither passes nor failures — they are gaps in what the data can answer, and they are excluded from the passed count above rather than folded into it.
With respect to 75% of total assets, no more than 5% may be invested in the securities of any one issuer.
Required>= 75.0%Actual68.5%Margin-6.5%No more than 25% of total assets may be invested in the securities of any one issuer.
Required<= 25.0%Actual33.8%Margin-8.8%The fund will not concentrate: no more than 25% of total assets in any one industry (excluding government securities and cash items).
Required<= 25.0%Actual36.2%Margin-11.2%Days required to liquidate the largest position at 20% of one day's dollar volume.
Required<= 7.0 daysActualunboundedMargin—
Engineering approximation of the cited rules for a DRAFT / HYPOTHETICAL model portfolio that is not a registered fund. This reports whether the portfolio passes the stated test AS IMPLEMENTED HERE; it is not a compliance opinion and is not a statement that any fund is compliant. Real filings need securities counsel.
No verdict sits within 1.0pp of its limit.
Data version — panel=20260719T025334 rows=2239262 asof=202607 issuers=20260719T014536 rates=20260804T224700
Measured on the 2026-07 formation date across 272 holdings (cap-weighted). A different formation date can produce different verdicts.
Derivatives risk (Rule 18f-4)
Whether this long-only book is subject to the VaR tests at all
This assessment describes the long-only book this fund holds — the top bucket only.
This fund QUALIFIES for the limited-derivatives-user exception, so it is excepted from the VaR tests; the ratio below is informational, not the operative limit.
Rule 18f-4(c)(4): a fund whose derivatives exposure (gross notional, including the value of assets sold short) is <= 10% of net assets is excepted from the VaR tests and the full derivatives risk management program.
No confidence interval: this follows from portfolio construction, not from an estimate.
Rule 18f-4(c)(2)(i): fund VaR at 99% over 20 trading days must not exceed 200% of the designated reference portfolio's VaR on the same basis.
Informational — does not governThis fund is excepted from the VaR tests, so the ratio below is context rather than the operative limit. It is shown because it is still a description of the book’s risk, not because it decides anything.
historical method · 331 monthly observations · about 3.3 in the 99% tail · paired percentile bootstrap over months
The estimators differ materially in value but agree on the verdict. Historical and Gaussian fund VaR differ by 18%; both still land on the same side of the 2x limit.
Engineering approximation of SEC Rule 18f-4 for research display. Not a compliance opinion and not a determination that any fund is compliant. Hypothetical model portfolio, not a registered fund.
The research long-short construction behind this factor does not qualify for this exception — a dollar-neutral book counts its full short notional, which is 100% of net assets against a 10% threshold. This product sidesteps that by holding the long leg alone, which is also why the long-leg Sharpe is reported separately throughout the site.
See the long-short verdict on the factor page →Since publication
Did the edge survive the paper coming out?
Split at January of the year after the factor was published. The post-publication stretch IS genuinely out-of-sample relative to the original study -- the predictor was public by then -- so it speaks to whether the effect survived being known. Nothing is fitted here, so this is performance SINCE PUBLICATION, not validation of a model. Note the 'pre' side is our data before publication (our panel starts ~1999), NOT the study's original in-sample period, which usually ran decades earlier; a decay figure compares before-vs-after within our sample and is not a comparison against the published result.
Consistency across eras
Is this record broadly durable, or one regime?
3-year rolling windows, stepping 1 year (26 windows). Dispersion is the spread of window Sharpes — higher means the record depends more on which era you look at.
Rules-based factors fit no parameters, so these windows are not out-of-sample tests and do not validate a fitted model. They show whether the factor's record is consistent across eras or driven by one regime.
Returns
Long leg is what this fund holds — long-short is shown for reference
| Period | Long leg | Long-short |
|---|---|---|
| 1 yearcum. | 24.1% | 22.7% |
| 3 yearsp.a. | 23.0% | 10.9% |
| 5 yearsp.a. | 13.3% | 6.6% |
| 10 yearsp.a. | 15.3% | 6.2% |
| Since inceptionp.a. | 10.4% | 4.0% |
| Year | Long leg | Long-short |
|---|---|---|
| 20267 mo | 14.5% | 12.8% |
| 2025 | 18.7% | 14.9% |
| 2024 | 33.3% | 14.6% |
| 2023 | 22.3% | 0.2% |
| 2022 | -22.4% | -2.7% |
| 2021 | 22.3% | -4.7% |
| 2020 | 23.4% | 10.2% |
| 2019 | 25.8% | 8.0% |
| 2018 | 5.6% | 23.3% |
| 2017 | 18.1% | -6.3% |
| 2016 | 8.3% | -13.9% |
| 2015 | 10.3% | 25.2% |
| 2014 | 14.6% | 19.6% |
| 2013 | 38.3% | 5.8% |
| 2012 | 14.6% | 6.0% |
| 2011 | 8.5% | 6.4% |
| 2010 | 13.5% | -12.8% |
| 2009 | 21.4% | -8.8% |
| 2008 | -24.3% | 45.3% |
| 2007 | 14.3% | 11.8% |
| 2006 | 13.4% | -6.2% |
| 2005 | 5.3% | -7.7% |
| 2004 | 4.9% | -13.5% |
| 2003 | 27.7% | -0.8% |
| 2002 | -32.3% | -19.4% |
| 2001 | -13.6% | 1.8% |
| 2000 | 9.3% | 19.0% |
| 1999 | 30.3% | 9.1% |
Long leg = the top bucket this fund holds; long-short additionally shorts the bottom bucket and is not achievable in a long-only vehicle. Trailing figures run through July 2026: 1 year is a plain cumulative 12-month return (cum.), 3 years and longer are annualised (p.a.). Years marked with a month count are partial. These match the fact sheet’s tables by construction. Hypothetical backtest, gross of the placeholder expense ratio and trading costs — not investor results.
Fund Facts
Methodology
The Foundry Operating Profitability Industry-Neutral Factor ETF tracks a rules-based model that ranks liquid U.S. common stocks, industry-neutralized within Fama-French industries, each month by a Operating Profitability signal and holds the top decile with the highest values. Signals are computed from point-in-time Sharadar fundamentals and total-return prices. The portfolio reconstitutes monthly and is cap-weighted within the long leg.
This is a hypothetical model portfolio for research display only — not a registered fund, not an offer, and not investment advice.
Documents (draft — hypothetical)
Auto-generated from the model’s metrics and current holdings. Every document is labeled DRAFT / hypothetical.
Objective, fees, strategy, and key risks.
Full strategy, model methodology, and risks.
Policies, construction, and governance.
One-page snapshot with top holdings.
Full current constituent list.
DRAFT — HYPOTHETICAL MODEL PORTFOLIO — NOT A REGISTERED FUND, NOT AN OFFER TO SELL SECURITIES, NOT INVESTMENT ADVICE.